Schrödinger scientists will be exhibiting and presenting at the 2011 GPCR & Kinase Targets: Advances in drug development from molecular to clinical, held at the Thistle City Barbican in London.

At 10:20 am on Thursday, April 14, Schrödinger Applications Scientist Daniel Cappel will be discussing the important role that binding site waters can play in ligand-protein recognition with "Hydration Site Thermodynamics Explain SAR for the A2A Adenosine Receptor." We look forward to meeting you there.